feed,title,long_url,short_url
Benzinga,Opiant Pharma Secures Additional BARDA Funding For Opioid Overdose Treatment,https://benzinga.com/general/biotech/22/08/28412539/opiant-pharma-secures-additional-barda-funding-for-opioid-overdose-treatment,https://bit.ly/3JGwhrm
Benzinga,CorMedix Slapped With Second FDA Rejection For DefenCath,https://benzinga.com/general/biotech/22/08/28412760/cormedix-slapped-with-second-fda-rejection-for-defencath,https://bit.ly/3JVygIF
Benzinga,"Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy",https://benzinga.com/general/biotech/22/08/28412151/mersana-gsk-ink-1-36b-biobuck-deal-for-cancer-focused-therapy,https://bit.ly/3BSt860
